Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal and systemic methotrexate for primary intraocular lymphoma
jRCTs021180038Completed
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in primary intraocular lymphoma (PIOL). Primary endpoint: recurrence. Started Apr 2014; status: completed.
02
Drugs
methotrexate
03
Conditions
primary intraocular lymphoma (PIOL)
Beyond the preview
Go deeper on jRCTs021180038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180038.